main-logo

ICD-10 Code D07.1 | Carcinoma in situ of vulva Symptoms, Diagnosis, Billing

Carcinoma in situ of the vulva is a non-invasive form of cancer characterized by abnormal cell growth confined to the vulvar epithelium. It is clinically significant due to its potential progression to invasive cancer if left untreated. The ICD-10 Code D07.1 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.

What is ICD-10 Code D07.1 for Carcinoma in situ of vulva?

ICD-10 Code D07.1 represents Carcinoma in situ of the vulva, indicating the presence of localized, non-invasive cancerous cells. This code is used in clinical documentation and billing when diagnosing patients with this condition, which may arise from factors such as HPV infection or chronic irritation. Accurate coding is essential for treatment planning and reimbursement.

ICD-10 Code D07.1 – Clinical Definition and Explanation of Carcinoma in situ of vulva

Carcinoma in situ of the vulva is primarily caused by factors such as human papillomavirus (HPV) infection, chronic inflammation, or irritation. It is crucial to address this condition promptly to prevent progression to invasive cancer. Regular screening and early intervention are vital for effective management.

Key Clinical Features:

  • Presence of abnormal vulvar lesions or growths.
  • Potential association with HPV infection.
  • Symptoms may include itching, pain, or bleeding.
  • Higher incidence in postmenopausal women.

ICD-10 Code D07.1 for Carcinoma in situ of vulva – SOAP Notes & Clinical Use

ICD-10 Code D07.1 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation and facilitating appropriate billing for services rendered.

What Does ICD-10 Code D07.1 for Carcinoma in situ of vulva Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D07.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Carcinoma in situ of the vulva. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D07.1 – Carcinoma in situ of vulva

Prompt treatment of Carcinoma in situ of the vulva is essential to prevent progression to invasive cancer. Treatment options may include surgical excision or topical therapies.

Antibiotic Therapy:

    Supportive Care:

    • Pain management with analgesics.
    • Counseling for emotional support.
    • Regular follow-up for monitoring.

    Infection Control:

      How to Document Symptoms of Carcinoma in situ of vulva (ICD-10 D07.1) in SOAP Notes

      Subjective:

      • Patient reports vulvar itching and discomfort.
      • History of HPV infection noted.
      • Patient mentions recent changes in vulvar appearance.
      • No significant past medical history reported.

      Objective:

      • Vulvar examination reveals abnormal lesions.
      • No signs of invasive disease on biopsy.
      • Vital signs stable.
      • No lymphadenopathy detected.
      card-topcard-bottom

      Secure, compliant, and built for trust

      HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

      Learn more
      hipaa-icon

      SOAP Note Guidelines for Diagnosing Carcinoma in situ of vulva (ICD-10 Code D07.1)

      Assessment:

      • Diagnosis: Carcinoma in situ of vulva, low-grade.
      • ICD-10 Code: D07.1.
      • Contributing factors: HPV infection and chronic irritation.
      • Severity: Non-invasive.

      Plan:

      • Refer for surgical excision of lesions.
      • Educate patient on HPV vaccination.
      • Schedule follow-up in 3 months for monitoring.
      • Consider topical therapy if indicated.

      Treatment & Plan Section for ICD-10 Code D07.1 – Carcinoma in situ of vulva

      • Surgical excision is the primary treatment.
      • Topical chemotherapy may be considered.
      • Regular follow-up appointments for monitoring.
      • Patient education on self-examination and symptom awareness.

      Using ICD-10 Code D07.1 for Carcinoma in situ of vulva in Billing & SOAP Note Compliance

      • Ensure accurate documentation of symptoms and findings.
      • Use D07.1 in appropriate clinical settings for billing.
      • Align treatment plans with clinical guidelines.
      • Include relevant CPT codes for procedures performed.

      ICD-10 Code D07.1 in Medical Billing and Insurance for Carcinoma in situ of vulva

      ICD-10 Code D07.1 is crucial for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services related to Carcinoma in situ of the vulva.

      Billing Notes:

      • Document all relevant patient history and findings.
      • Use D07.1 in conjunction with procedure codes for surgical interventions.
      • Ensure compliance with payer-specific documentation requirements.
      • Review coding guidelines regularly to maintain accuracy.

      Common CPT Pairings:

      CPT CodeDescription
      12001Simple repair of superficial wounds, face, ears, eyelids, scalp, neck.
      11420Excision, benign lesion including margins, face, ears, eyelids, scalp, neck.
      58661Laparoscopy, surgical; with fulguration of endometriosis.
      88305Level IV surgical pathology, gross and microscopic examination.

      Frequently Asked Questions

      Common Questions About Using ICD-10 Code D07.1 for Carcinoma in situ of vulva

      What are the risk factors for Carcinoma in situ of the vulva?

      Risk factors include HPV infection, smoking, immunosuppression, and chronic vulvar irritation. Women with a history of vulvar lesions or those who are immunocompromised are at higher risk.

      How is Carcinoma in situ of the vulva diagnosed?

      Diagnosis typically involves a physical examination, biopsy of the vulvar lesions, and histopathological analysis to confirm the presence of carcinoma in situ.

      What treatment options are available for Carcinoma in situ of the vulva?

      Treatment options include surgical excision of the lesions, topical chemotherapy, and close monitoring. The choice of treatment depends on the extent and characteristics of the lesions.

      Is Carcinoma in situ of the vulva contagious?

      Carcinoma in situ of the vulva is not contagious. However, the underlying HPV infection can be transmitted through sexual contact, highlighting the importance of vaccination and safe practices.

      diamond-bg
      diamond-bg

      Get started with your 20 free notes

      Sign up for free
      main-logo

      AI-aided Sudsy Shorthand for ink-free practices

      support@soapsuds.io
      hipaa-logo

      Clinical Notes

      SOAP notes

      DAP notes

      AI medical notes

      © Copyright SOAPsuds 2025. All rights reserved